The role of the calcium-sensing receptor in the pathophysiology of secondary hyperparathyroidism

NDT Plus

Volumn 1, Issue SUPPL.1, 2008, Pages

  Riccardi, Daniela ^a   Martin, David ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b AMGEN INC   (United States)

Author keywords

Calcium sensing receptor; Chronic kidney disease; Cinacalcet; Parathyroid hormone; Secondary hyperparathyroidism

Indexed keywords

CALCIMIMETIC AGENT; CALCIUM SENSING RECEPTOR; CINACALCET; G PROTEIN COUPLED RECEPTOR; GADOLINIUM; MAGNESIUM ION; NEOMYCIN; R 568; SPERMINE; UNCLASSIFIED DRUG;

CALCIUM SIGNALING; CELL SURFACE; CONFERENCE PAPER; DISEASE COURSE; DRUG MECHANISM; HUMAN; NONHUMAN; PARATHYROID CELL; PARATHYROID HORMONE RELEASE; PARATHYROID HYPERPLASIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR DOWN REGULATION; SECONDARY HYPERPARATHYROIDISM; UREMIA;

EID: 39349099289     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfm038     Document Type: Conference Paper

References (46)

1. Brown EM, Gamba G, Riccardi D et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580
2. Garrett JE, Capuano IV, Hammerland LG et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 1995; 270: 12919-12925
3. Riccardi D, Park J, Lee WS, Gamba G, Brown EM, Hebert SC. Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci USA 1995; 92: 131-135
4. Brauner-Osborne H, Jensen AA, Sheppard PO, O'Hara P, Krogsgaard-Larsen P. The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain. J Biol Chem 1999; 274: 18382-18386
5. 2+-sensing receptor (CaR) activates phospholipases C, A2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells. J Bone Miner Res 1997; 12: 715-725
6. Kifor O, MacLeod RJ, Diaz R et al. Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol 2001; 280: F291-F302
7. Hofer AM, Brown EM Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol 2003; 4: 530-538
8. Nemeth EF, Steffey ME, Hammerland LG et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 1998; 95: 4040-4045
9. 2+ in bovine parathyroid cells evoked by extracellular divalent cations. Evidence for a cell surface calcium receptor. J Biol Chem 1987; 262: 5188-5196
10. Goldsmith PK, Fan GF, Ray K et al. Expression, purification, and biochemical characterization of the amino-terminal extracellular domain of the human calcium receptor. J Biol Chem 1999; 274: 11303-11309
11. 2+ receptor. J Biol Chem 1999; 274: 27642-27650
12. 2+ binding pocket within the venus flytrap module of the human calcium-sensing receptor. J Biol Chem 2005; 280: 37917-37923
13. 2+-sensing receptor. J Biol Chem 2007; 282(26): 19000-10
14. 2+. J Biol Chem 2005; 280: 5113-5120
15. Kunishima N, Shimada Y, Tsuji Y et al. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 2000; 407: 971-977
16. K/DOQI Guidelines. 2003. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S1-S201
17. Rodriguez M, Nemeth E, Martin D. The calcium-sensing receptor: A key factor in the pathogenesis of secondary hyperparathyroidism. Am J Physiol 2005; 288: F253-F264
18. Tominaga Y. Mechanism of parathyroid tumourigenesis in uraemia. Nephrol Dial Transplant 1999; 14(Suppl 1): 63-65
19. Naveh-Many T, Rahamimov R, Livni N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 1995; 96: 1786-1793
20. Slatopolsky E, Finch J, Denda M et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996; 97: 2534-2540
21. Cozzolino M, Lu Y, Finch J, Slatopolsky E, Dusso AS. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int 2001; 60:2109-2117
22. Harper JW, Adami GR, Wei N, Keyomarsi Y, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816
23. Pagano M, Pepperkok R, Lukas J et al. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol 1993; 121: 101-111
24. Matsuura I, Denissova WG, Wang G, He D, Long J, Liu F. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 2004; 430: 226-231
25. Dusso A, Cozzolino M, Lu Y, Sato T, Slatopolsky E. 1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: A mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure. J Steroid Biochem Mol Biol 2004; 89-90: 507-511
26. Dusso AS, Pavlopoulos T, Naumovich L et al. p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int 2001; 59: 855-865
27. Canalejo A, Almaden Y, Torregrosa V et al. The in vitro effect of calcitriol on parathyroid cell proliferation and apoptosis. J Am Soc Nephrol 2000; 11: 1865-1872
28. Ritter CS, Finch JL, Slatopolsky EA, Brown AJ. Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor. Kidney Int 2001; 60: 1737-1744
29. Brown AJ, Ritter CS, Finch JL, Slatopolsky EA. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Kidney Int 1999; 55: 1284-1292
30. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81: 1598-1606
31. Canadillas S, Canalejo A, Santamaria R et al. Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyrdid glands from humans. J Am Soc Nephrol 2005; 16: 2190-2197
32. Gogusev J, Duchambon P, Hory B et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with. hyperparathyroidism. Kidney Int 1997; 51: 328-336
33. 3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 1985; 35: 1049-1056
34. Nagano N. Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative apprbach to controlling hyperparathyroidism. Pharmacol Ther 2006; 109: 339-365
35. Nemeth EF, Heaton WH, Miller M et al. Pharmacodynamics of the type JJ calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther 2004; 308: 627-635
36. Nemeth EF. Calcimimetic and calcilytic drugs: Just for parathyroid cells? Cell Calcium 2004; 35: 283-289
37. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 1986; 78: 1296-1301
38. Silver J, Moallem E, Kilav, R, Sela A, Naveh-Many T. Regulation of the parathyroid hormone gene by calcium, phosphate and 1,25-dihydroxyvitamin D. Nephrol Dial Transplant 1998; 13(Suppl 1): 40-44
39. Naveh-Many T, Silver J. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Clin Invest 1990; 86: 1313-1319
40. Moallem E, Kilav R, Silver J, Naveh-Many T. RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J Biol Chem 1998; 273: 5253-5259
41. Antonsen JE, Sherrard DJ, Andress DL. A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication. Kidney Int 1998; 53: 223-227
42. Colloton M, Shatzen E, Miller G et al. Cinacticet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism. Kidney Int 2005; 67: 467-476
43. Kawata T, Imanishi Y, Kobayashi K et al. Direct in vitro evidence of the suppressive effect of cinacalcet HCl onparathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels. J Bone Miner Melab 2006; 24: 300-306
44. Padhi D, Han is RZ, Salfi M, Sullivan JT. No effect of renal function or dialysis on pharmacokinetics of cinacalcet (Sensipar/Mimpara). Clin Pharmacokinet 2005; 44: 509-516
45. Mizobuchi M, Hatanium I. Ogata H et al. Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency. J Am Soc Nephrol 2004; 15: 2579-2587
46. Davis J, Miller J. Shatzen E, Henley C, Martin D. Cinacalcet HCl increases expression of p21 in the parathyroid and reversibly inhibits parathyroid hyperplasia in a rodent model of CKD (Abstract). Nephrol Dial Transplant 2005; 20: V205